Cargando…
Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)
Renal cell carcinoma (RCC) is diagnosed in >200,000 individuals worldwide each year, accounting for ~2% of all cancers, but the spread of this disease amongst genders is distinctly uneven. In the U.S. the male:female incidence ratio is approximately 2:1. A potential hypothesis is mutation spectra...
Autores principales: | Ricketts, Christopher J., Linehan, W. Marston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618848/ https://www.ncbi.nlm.nih.gov/pubmed/26484545 http://dx.doi.org/10.1371/journal.pone.0140257 |
Ejemplares similares
-
Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project
por: Ricketts, Christopher J., et al.
Publicado: (2014) -
MicroRNA Profiling of Morphologically Heterogeneous Clear Cell Renal Cell Carcinoma
por: Giubellino, Alessio, et al.
Publicado: (2021) -
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
por: Zhengqi, Qiu, et al.
Publicado: (2021) -
Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018) -
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)